Long-term survival in unfavorable-risk mRCC patients treated with a combination of autologous immunotherapy (AGS-003) plus sunitinib. Meeting Abstract

cited authors

  • Amin, Asim; Dudek, Arkadiusz Z.; Logan, Theodore F.; Lance, Raymond S.; Holzbeierlein, Jeffrey M.; Master, Viraj A.; Pal, Sumanta Kumar; Knox, Jennifer J.; Karsh, Lawrence Ivan; Plessinger, Doug; Nicolette, Charles A.; Figlin, Robert A.; AGS-003-006 Study Grp

Publication Date

  • May 20, 2014

webpage

published in

category

volume

  • 32

issue

  • 15